RVL Pharmaceuticals plc XNAS: RVLP

Watchlist

Portfolio

Alert

Share
36.9

Operating Revenue TTM

Below industry Median
-68.3

Net profit TTM

Negative Net profit TTM
-184.9

Net Profit Margin TTM %

5.6

Operating Revenue growth TTM %

Below industry Median
-20.8

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
Board Meeting
The next board meeting for RVL Pharmaceuticals plc is on 01 Aug 2025 for the purpose of RVL Pharmaceuticals PLC First Quarter Earnings Result for 2025 See details

RVL Pharmaceuticals plc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents